Triazaverin Prophylactic Efficacy Against Influenza Virus A (H5N1)

Triazaverin Prophylactic Efficacy Against Influenza Virus A (H5N1)

The experimental study of the prophylactic efficacy of Triazaverin against the experimental form of the influenza virus A (H5N1) on albino mice intranasally infected with the influenza virus A/Chicken/Kurgan/Russia/02/05 vs. the reference drugs Tamiflu®, Remantadin and Arbidol® showed that in doses...

Full description

Saved in:
Bibliographic Details
Main Authors: S. YA. Loginova, S. V. Borisevich, B. A. Maksimov, V. P. Bondarev, S. K. Kotovskaya, V. L. Rusinov, V. N. Charushin, O. N. Chupakhin
Format: Article
Language:Russian
Published: LLC "Publishing House OKI" 2020-05-01
Series:Антибиотики и Химиотерапия
Subjects:
influenza virus a
triazaverin
antiviral efficacy
prophylaxis
Online Access:https://www.antibiotics-chemotherapy.ru/jour/article/view/330
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.antibiotics-chemotherapy.ru/jour/article/view/330

Similar Items